During the past decade, Sampson Radiation Oncology conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 16 clinical trials were completed, i.e. on average, 123.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sampson Radiation Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "SWOG Cancer Research Network" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored and "GOG Foundation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sampson Radiation Oncology" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Sampson Radiation Oncology" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Cervical Adenocarcinoma" (2 trials), "Cervical Adenosquamous Carcinoma" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Sampson Radiation Oncology" in a lesser frequency.

Most popular intervention types in "Sampson Radiation Oncology" are "Drug" (23 trials), "Other" (21 trials), "Biological" (8 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (15 trials), "Quality-of-Life Assessment" (8 trials), "Docetaxel" (4 trials), "Tamoxifen Citrate" (3 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sampson Radiation Oncology" are 17 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Sampson Radiation Oncology". undefined are not yet recruiting, undefined are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sampson Radiation Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sampson Radiation Oncology, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".